nifedipine has been researched along with Marfan Syndrome in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Civilibal, M | 1 |
| Calişkan, S | 1 |
| Numan, F | 1 |
| Bariş, S | 1 |
| Doğan, D | 1 |
| Kasapçopur, O | 1 |
| Sever, L | 1 |
| Cantaşdemir, M | 1 |
| Arisoy, N | 1 |
| Syyong, HT | 1 |
| Chung, AW | 1 |
| van Breemen, C | 1 |
2 other studies available for nifedipine and Marfan Syndrome
| Article | Year |
|---|---|
Renovascular hypertension in a child with Marfan syndrome.
Topics: Adolescent; Angiography, Digital Subtraction; Blood Pressure; Female; Humans; Hypertension, Renovasc | 2010 |
Marfan syndrome decreases Ca2+ wave frequency and vasoconstriction in murine mesenteric resistance arteries without changing underlying mechanisms.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Signaling; Cations, Divalent; Disease Models, An | 2011 |